Immuno-Oncology: a concept or already a reality?

Prof. Peter Johnson - Cancer Research UK Centre, University of Southampton, UK
Immuno-Oncology: a concept or already a reality? ( Prof. Peter Johnson - Cancer Research UK Centre, University of Southampton, UK )
3 Dec 2013

Why are Immuno-Oncology compounds different?

Prof. Enriqueta Felip - Vall d'Hebron University Hospital, Barcelona, Spain
Why are Immuno-Oncology compounds different? ( Prof. Enriqueta Felip - Vall d'Hebron University Hospital, Barcelona, Spain )
3 Dec 2013

New guidelines for cervical cancer

Dr Nathalie Broutet – World Health Organization, Geneva, Switzerland
New guidelines for cervical cancer ( Dr Nathalie Broutet – World Health Organization, Geneva, Switzerland )
3 Dec 2013

Implementation of radical hysterectomy surgery education in Kenya

Dr Barry Rosen - University of Toronto, Canada
Implementation of radical hysterectomy surgery education in Kenya ( Dr Barry Rosen - University of Toronto, Canada )
27 Nov 2013

Uptake of low cost cervical cancer screening in Africa

Dr Chibuike Chigbu - University of Nigeria Teaching Hospital, Enugu
Uptake of low cost cervical cancer screening in Africa ( Dr Chibuike Chigbu - University of Nigeria Teaching Hospital, Enugu )
27 Nov 2013

What does science tell us about current screening recommendations?

Dr Edward Trapido - LSU Health Science Center, New Orleans, USA
What does science tell us about current screening recommendations? ( Dr Edward Trapido - LSU Health Science Center, New Orleans, USA )
22 Nov 2013

Policies around screening and early detection programs in low and middle income countries

Dr Edward Trapido - LSU Health Science Center, New Orleans, USA
Policies around screening and early detection programs in low and middle income countries ( Dr Edward Trapido - LSU Health Science Center, New Orleans, USA )
22 Nov 2013

Engineering of polymeric nanoparticles for medical applications

Dr Omid Farokhzad - Harvard Medical School, Boston, USA
Engineering of polymeric nanoparticles for medical applications ( Dr Omid Farokhzad - Harvard Medical School, Boston, USA )
14 Nov 2013

PETROC / OV21: Phase II/III trial of peritoneal treatment for ovarian cancer

Dr Chris Gallagher - Barts and the London NHS Trust, UK
PETROC / OV21: Phase II/III trial of peritoneal treatment for ovarian cancer ( Dr Chris Gallagher - Barts and the London NHS Trust, UK )
12 Nov 2013

Future perspectives: realising the potential of personalised healthcare in gynaecological cancer

Dr Jonathan Ledermann - University College London, United Kingdom
Future perspectives: realising the potential of personalised healthcare in gynaecological cancer ( Dr Jonathan Ledermann - University College London, United Kingdom )
8 Nov 2013

The revolution in personalised healthcare: Towards improved outcomes in oncology: Conclusion and Summary

Dr Frances Shepherd - Princess Margaret Hospital and the University of Toronto, Canada
The revolution in personalised healthcare: Towards improved outcomes in oncology: Conclusion and Summary ( Dr Frances Shepherd - Princess Margaret Hospital and the University of Toronto, Canada )
8 Nov 2013

Advances in geriatric, medical oncology

Prof Stuart Lichtman - Memorial Sloan Kettering Cancer Center, New York, USA
Advances in geriatric, medical oncology ( Prof Stuart Lichtman - Memorial Sloan Kettering Cancer Center, New York, USA )
7 Nov 2013